Filip De Vos
University Medical Center Utrecht
58 papers found
Refreshing results…
Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial
UploadInfigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study
UploadMissing publications? Search for publications with a matching author name.